cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults
Identification
- Clé publique
- radar:r-8f4c73cd1e3a047d4d40551824016c68
- Auteurs
- Laura Fertitta · Kavita Sarin · Christina Bergqvist · Ekshika Patel · Bastien Peiffer · Sabine Moryousef · Marie-Laure Armand · Arnaud Jannic · Salah Ferkal · Philippe Ravaud · Viet-Thi Tran · Jaishri Blakeley · Carlos Romo · Khaled Ezzedine · Pierre Wolkenstein
- Année déclarée
- —
- Langue déclarée
- en
- Type source
- ART
- Première détection
- 2026-11-13T08:56:02.133601+00:00
- Dernière observation des métadonnées
- 2026-11-13T08:56:02.133601+00:00
- Dernière vérification HTTP
- Non effectuée
Institutions déclarées par la source
AP-HP - Hôpital Necker - Enfants Malades · Assistance publique - Hôpitaux de Paris · AP-HP - Hôpital Henri-Mondor · Groupe Henri Mondor-Albert Chenevier · CIC - CHU Henri Mondor · Institut National de la Santé et de la Recherche Médicale · Université Paris-Est Créteil Val-de-Marne - Paris 12 · Methods of therapeutic evaluation of chronic diseases | Méthodes de l’évaluation thérapeutique des maladies chroniques · Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques · Université Paris Cité · Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement · Centre d'épidémiologie Clinique [Hôtel-Dieu] · Hôpital Hôtel-Dieu [Paris] · Johns Hopkins University School of Medicine [Baltimore]
Résumé documentaire — langue originale
Importance Just-in-time interventions (JITIs) are a type of digital therapeutic intervention that combines remote monitoring tools and algorithms to personalize the delivery of specific interventions at the right time. The US Food and Drug Administration (FDA) regulatory approval documents are often the only available source of information on the effectiveness of therapeutic interventions based on these devices. Objective To systematically review the publicly available information from the FDA on all recently approved medical devices used in JITIs to (1) assess how they operate to deliver JITIs and (2) appraise the evidence supporting their performance and clinical effectiveness. Evidence Review Two reviewers systematically searched the Premarket Notifications (510(k)), Premarket Approvals, De Novo, and Humanitarian Device Exemption databases from January 2019 to December 2021 for all entries associated with devices that monitored patients’ data over time to personalize the delivery of interventions to treat, prevent, or mitigate health conditions or events. They assessed whether the product summaries (1) enabled an understanding of how the device operated to deliver a JITI (eg, the nature, type, and frequency of the monitoring, the nature of the decision algorithm, and the nature and intended receiver of the intervention); (2) informed about the performance and effectiveness of the JITI; and (3) included information on data security and ownership. Findings In total, 38 devices were included in this review. These were mainly intended for cardiac conditions (12 [31.6%]), diabetes (10 [26.3%]), and neurological diseases (4 [10.5%]). Monitoring devices ranged from wearable (18 of 28 [64.4%]; eg, smartwatches) to implanted sensors (6 of 28 [21.4%]; eg, inserted electrocardiographic sensors). Only 10 of 38 product summaries (26.3%) allowed a full understanding of how the device operated to deliver a JITI. Similarly, only 12 of 28 (42.9%), 12 of 36 (33.3%), and 5 of 38 (13.2%) reported the assessment of the performance of the monitoring device, assessment of the decision algorithm, and results of clinical studies assessing the effectiveness of the JITI, respectively. Finally, 14 of 36 product summaries (38.9%) included some information on data security, but none included information on data ownership. Conclusion and Relevance The results of this systematic review suggest that the information publicly available in the FDA databases on the performance and effectiveness of digital medical devices used in JITIs is heterogeneous.
Identifiants
- DOI
- 10.1016/j.jid.2023.04.014
- HAL
- hal-04369802
Repères documentaires
- Famille documentaire
- article
- Types déclarés par les sources
- ART
Les mentions d’entités ne constituent pas une preuve de reconnaissance juridique. La juridiction étudiée est distincte du pays d’affiliation des auteurs.
Sources
HAL · Document 1
Citer cette référence
Laura Fertitta; Kavita Sarin; Christina Bergqvist; Ekshika Patel; Bastien Peiffer; Sabine Moryousef; Marie-Laure Armand; Arnaud Jannic; Salah Ferkal; Philippe Ravaud; Viet-Thi Tran; Jaishri Blakeley; Carlos Romo; Khaled Ezzedine; Pierre Wolkenstein. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. https://doi.org/10.1016/j.jid.2023.04.014
JSON · CSL-JSON · BibTeX · RIS · CSV · JSON-LD ·
APA, Chicago, ISO 690 : formats bibliographiques fondés sur les champs disponibles. OSCOLA / Bluebook : données structurées uniquement ; aucune conformité juridique complète n’est revendiquée sans vérification des éléments nécessaires.
- APA
- Laura Fertitta; Kavita Sarin; Christina Bergqvist; Ekshika Patel; Bastien Peiffer; Sabine Moryousef; Marie-Laure Armand; Arnaud Jannic; Salah Ferkal; Philippe Ravaud; Viet-Thi Tran; Jaishri Blakeley; Carlos Romo; Khaled Ezzedine; Pierre Wolkenstein. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. https://doi.org/10.1016/j.jid.2023.04.014
- Chicago
- Laura Fertitta; Kavita Sarin; Christina Bergqvist; Ekshika Patel; Bastien Peiffer; Sabine Moryousef; Marie-Laure Armand; Arnaud Jannic; Salah Ferkal; Philippe Ravaud; Viet-Thi Tran; Jaishri Blakeley; Carlos Romo; Khaled Ezzedine; Pierre Wolkenstein. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. https://doi.org/10.1016/j.jid.2023.04.014
- ISO 690
- Laura Fertitta; Kavita Sarin; Christina Bergqvist; Ekshika Patel; Bastien Peiffer; Sabine Moryousef; Marie-Laure Armand; Arnaud Jannic; Salah Ferkal; Philippe Ravaud; Viet-Thi Tran; Jaishri Blakeley; Carlos Romo; Khaled Ezzedine; Pierre Wolkenstein. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. https://doi.org/10.1016/j.jid.2023.04.014
Warning: Undefined array key "last_link_verified" in /home/clients/e27d81e12f04d2bfd747aa264540ac56/sites/_UDTR_APP/legal_library_reference.php on line 31
UDTR — Bibliothèque juridique mondiale des droits de la Nature. cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults. Notice documentaire: https://www.declarationuniverselledesdroitsdelarbre.org/global-rights-of-nature-radar/reference/r-8f4c73cd1e3a047d4d40551824016c68/ · Dernière vérification HTTP : non effectuée
Données de cette version figée
Dossiers et relations documentaires
Rôles des sources
Source bibliographique / publication d’origine · https://hal.science/hal-04369802v1
Un lien vers une autorité ne prouve pas à lui seul une affirmation juridique. Les résumés et les textes intégraux restent soumis aux conditions de leur source.
Statut documentaire
Pertinence à examiner
Bibliothèque
Cette identité n’est pas encore intégrée à la Bibliothèque juridique.